Choongwe: New quinolone compound Q-35 on clinical phase III

A new quinolone antibacterial drug, Q35 (Curoxin) will be performed its phase III clinical study accorded to the ICH standards at 13 hospitals including SNU hospital, starting from April, said Choongwe on April 22.

Choongwe obtained the approval for the phase III clinical study from the KFDA after due evaluation of the Central Drug Deliberation Commission in Dec. last year, and it seems to b...